Diabetes and Prediabetes and Risk of Hospitalization: The Atherosclerosis Risk in Communities (ARIC) Study by Schneider, Andrea L. C. et al.
Diabetes and Prediabetes and
Risk of Hospitalization:
The Atherosclerosis Risk
in Communities (ARIC) Study
Diabetes Care 2016;39:772–779 | DOI: 10.2337/dc15-1335
OBJECTIVE
To examine the magnitude and types of hospitalizations among persons with
prediabetes, undiagnosed diabetes, and diagnosed diabetes.
RESEARCH DESIGN AND METHODS
This study included 13,522 participants in the Atherosclerosis Risk in Communities
(ARIC) study (mean age 57 years, 56% female, 24% black, 18% with prediabetes,
4% with undiagnosed diabetes, 9% with diagnosed diabetes) with follow-up in
1990–2011 for hospitalizations. Participants were categorized by diabetes/HbA1c
status: without diagnosed diabetes, HbA1c <5.7% (reference); prediabetes, 5.7 to
<6.5%; undiagnosed diabetes, ‡6.5%; and diagnosed diabetes, <7.0 and ‡7.0%.
RESULTS
Demographic adjusted rates per 1,000 person-years of all-cause hospitalizations
were higher with increasing diabetes/HbA1c category (Ptrend < 0.001). Persons
with diagnosed diabetes and HbA1c ‡7.0% had the highest rates of hospitalization
(3.1 times higher than those without a history of diagnosed diabetes, HbA1c
<5.7%, and 1.5 times higher than those with diagnosed diabetes, HbA1c <7.0%,
P< 0.001 for both comparisons). Personswith undiagnosed diabetes had 1.6 times
higher rates of hospitalization and those with prediabetes had 1.3 times higher
rates of hospitalization than those without diabetes and HbA1c <5.7% (P < 0.001
for both comparisons). Rates of hospitalization by diabetes/HbA1c category were
different by race (Pinteraction = 0.011) and by sex (Pinteraction = 0.020). There were
significantly excess rates of hospitalizations due to cardiovascular, endocrine,
respiratory, gastrointestinal, iatrogenic/injury, neoplasm, genitourinary, neuro-
logic, and infection causes among those with diagnosed diabetes compared with
those without a history of diagnosed diabetes (all P < 0.05).
CONCLUSIONS
Persons with diagnosed diabetes, undiagnosed diabetes, and prediabetes are at a
significantly elevated risk of hospitalization compared with those without diabe-
tes. Substantial excess rates of hospitalizations in persons with diagnosed diabe-
tes were for endocrine, infection, and iatrogenic/injury causes, which may be
preventable with improved diabetes care.
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The burden of diabetes and prediabetes
in the U.S. is high (1,2). Approximately
21 million adults aged 20 years or older
had either diagnosed or undiagnosed
diabetes in 2010 (1). Diabetes rep-
resents a significant and increasing pro-
portion of U.S. health care costs (3,4). In
2012, the total estimated cost of diag-
nosed diabetes was 245 billion dollars
(compared with 174 billion dollars in
2007) (5,6). Overall, inpatient hospitali-
zations account for the majority of all
medical expenditures (7). Indeed, the
largest component of diabetes-related
medical expenditures in 2012 was re-
lated to inpatient hospital care, which
comprised ;43% of the total esti-
mated cost (5). However, the magni-
tude of risk of all-cause hospitalization
and the different causes of hospitali-
zations that occur among persons with
prediabetes and persons with diabe-
tes are not well characterized.
The objective of this study was to ex-
amine the relationships between pre-
diabetes, undiagnosed diabetes, and
diagnosed diabetes with all-cause and
cause-specific hospitalizations occurring
over a median of 20 years of follow-up
among middle-aged white and black
persons in the community-based Ath-
erosclerosis Risk in Communities (ARIC)
study and to evaluate possible interac-
tions by age, race, and sex. We hypoth-
esized that persons with prediabetes,
undiagnosed diabetes, and diagnosed
diabetes would have higher rates of hos-
pitalization, especially from cardiovas-
cular causes, than those without
diabetes and that, in addition to endo-
crine causes, infectious and iatrogenic/
injury (e.g., postoperative complica-
tions, fractures, etc.) causes would
represent a substantial burden of hos-
pitalizations among persons with dia-
betes. We further hypothesized that
among persons with diagnosed diabetes,
higher HbA1c ($7.0%) would be associ-
ated with higher rates of all-cause hospi-
talization compared with those with
lower HbA1c (,7.0%).
RESEARCH DESIGN AND METHODS
Study Population
The ARIC study population is com-
prised of an ongoing, prospective co-
hort of 15,792 participants recruited
in 1987–1989 (visit 1) from four sites:
suburbs ofMinneapolis,MN;Washington
County, MD; Forsyth County, NC; and
Jackson, MS (8). Participants have sub-
sequently attended four additional in-
person visits in 1990–1992 (visit 2),
1993–1995 (visit 3), 1996–1998 (visit 4),
and 2011–2013 (visit 5). The ARIC study
has been approved by the institutional
review boards of all participating insti-
tutions, and all participants gave writ-
ten informed consent at each study
visit.
HbA1cwasfirstmeasured atARIC visit 2;
therefore, visit 2 (1990–1992) is the
baseline for the current study. Of the
14,348 participants who attended ARIC
visit 2, we excluded 283 participants
missing HbA1c or fasting glucose data,
90 participants of self-reported non-
white and nonblack race or of black
race from the Minnesota or Maryland
sites, 3 participants without follow-up
after visit 2, and 450 participants missing
data on covariates included in statisti-
cal models, leaving a total of 13,522
participants included in the present
analyses.
Definition of Diabetes and
Measurement of HbA1c and
Fasting Glucose
Diagnosed diabetes at visit 2 was de-
fined by self-report of a physician di-
agnosis or diabetes medication use.
Frozen whole-blood samples collected
at ARIC vis it 2 (1990–1992) were
thawed and assayed for the measure-
ment of HbA1c using high-performance
liquid chromatography (Tosoh A1c 2.2
Plus Glycohemoglobin Analyzer method
in 2003–2004 and Tosoh G7 method in
2007–2008, Tosoh Corporation, Tokyo,
Japan) (9). Both instruments were stan-
dardized to the Diabetes Control and
Complications Trial assay (10). Glucose
was measured in 1990–1992 using the
hexokinase method. All participants
were asked at each visit if they wanted
abnormal laboratory results sent to
their primary care physician for clinical
interpretation. If abnormal (defined as
$140 mg/dL in 1990–1992), fasting
glucose results would be sent to the
primary care doctor of participants
who opted in for notification. However,
since HbA1c was measured .10 years
after blood samples were drawn, data
on HbA1c were not sent to primary care
physicians.
We categorized persons without a
history of diagnosed diabetes according
to clinical categories of HbA1c: ,5.7%
(reference), 5.7 to,6.5% (prediabetes),
and$6.5% (undiagnosed diabetes) (11).
In our main analysis, participants with
diagnosed diabetes were categorized
as having HbA1c ,7.0 or $7.0%
(12,13). We additionally performed a
sensitivity analysis using an HbA1c cut
point of 8.0% (12,13). In supplementary
analyses, we classified participants by
diabetes/fasting glucose category. Par-
ticipants without a history of diagnosed
diabetes were classified as follows:
,100 mg/dL (reference), 100 to ,126
mg/dL (prediabetes), and $126 mg/dL
(undiagnosed diabetes) (11). Partici-
pants with diagnosed diabetes were
classified as having fasting glucose
,150 or $150 mg/dL.
Ascertainment of Hospitalizations
and Definition of Hospitalization
Categories
We used data that the ARIC study ascer-
tained through hospitalization reports
from annual telephone contact with
study participants and through active
surveillance of hospitalizations occur-
ring in the study community hospitals.
For the current study, follow-up was
available from baseline through 31
December 2011. The first ICD-9 code
listed in the hospital discharge documen-
tation defined the primary cause for
hospitalization.
Our main outcome was counts of all-
cause hospitalizations. We categorized
the primary cause of each hospitali-
zation using the Clinical Classification
Software developed by the Agency for
Healthcare Research and Quality (https://
www.hcupus.ahrq.gov/toolssoftware/ccs/
ccs.jsp) (14). The primary cause of each
hospitalization was classified into 18
systems-based categories and then
subclassified into 285 disease-based
categories (14). In sensitivity analyses,
we recategorized all infection-related
ICD-9 diagnoses to create a more com-
prehensive infection category, as not
all ICD-9 codes that identified infection
were classified in the infection cate-
gory as defined by the Clinical Classifica-
tion Software (for example, pneumonia
was classified under the respiratory
system and not the infection category
with use of the Clinical Classification
Software).
Statistical Analyses
Baseline characteristics of the study pop-
ulation are shown by diabetes/HbA1c
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category. t tests were used to compare
means for continuous variables, and x2
tests were used to compare proportions
for categorical variables. Numbers of all-
cause and cause-specific hospitalizations
were tabulated by diabetes/HbA1c cate-
gory. Crude rates of all-cause hospitaliza-
tion were calculated by diabetes/HbA1c
category and by 10-year age categories
(,60, 60–69, 70–79, and $80 years,
with each participant contributing person-
time and events to separate 10-year
age bins from baseline to death or cen-
soring). Negative binomial regression
models were used to calculate adjusted
rates of hospitalization per 1,000 person-
years (95% CI) when all continuous
covariates were set to mean values and
all categorical covariates were set to the
reference group by diabetes/HbA1c cat-
egory, with persons with no history of
diagnosed diabetes and HbA1c ,5.7%
serving as the reference group. In the
negative binomial regression models,
follow-up time (defined as the time from
baseline [visit 2] to censoring [31 Decem-
ber 2011] or death) was an offset vari-
able, which serves to account for the
competing risk of death. The negative
binomial model was preferred over the
Poisson model for our data due to over-
dispersion (likelihood ratio test of a = 0
was significant at P , 0.001). We tested
for linear trend across the median of the
diabetes/HbA1c categories. In additional
sensitivity analyses, we also considered
zero-inflated negative binomial models
to calculate adjusted rates of hospitali-
zation per 1,000 person-years (95% CI)
by diabetes/HbA1c category because
23% of our population was never hospi-
talized during follow-up. Akaike informa-
tion criterion and the Vuong test were
used to assess goodness of fit for our
models. In additional sensitivity anal-
yses, we used negative binomial regres-
sion models to calculate adjusted rates
of hospitalization per 1,000 person-
years (95% CI) when all continuous covar-
iates were set to mean values and all
categorical covariates were set to the ref-
erence group by diabetes/fasting glucose
category. We formally tested for multipli-
cative interaction by age, race, and sex in
our main statistical models.
All covariates used in statistical mod-
els were assessed at visit 2 (1990–1992)
unless otherwise stated. Covariates in
the main statistical model included the
following: age (continuous), sex (male,
female), race/center (Minnesota whites
[reference], Maryland whites, North
Carolina whites, North Carolina blacks,
Mississippi blacks), and health insurance
(yes, no [reference]). We additionally
ran a model further adjusted for the
Charlson Comorbidity Index (dichoto-
mized as low comorbidity burden [score
,2] vs. high comorbidity burden [score
$2]) (15–17). A supplemental statistical
model added the following covariates:
education (,high school [reference];
high school or equivalent; college, grad-
uate or professional school; assessed at
visit 1), family income (,$35,000/year
[reference], $$35,000/year, not re-
ported), BMI (continuous [measured
as weight in kilograms divided by the
square of height in meters]), cigarette
smoking (current, former, never [refer-
ence]), alcohol consumption (current,
former, never [reference]), systolic
and diastolic blood pressure (continu-
ous [mmHg]), hypertension medication
use (yes, no [reference]), coronary
heart disease (yes, no [reference]), total
and HDL cholesterol (continuous [mg/dL]),
cholesterol medication use (yes, no
[reference]), and estimated glomeru-
lar filtration rate (continuous; cal-
culated using the Chronic Kidney
Disease Epidemiology Collaboration
formula [18]).
Since we were unable to perform
analyses using time-varying diabetes/
HbA1c categories (as HbA1c was only
measured at visit 2 in 1990–1992), we
performed sensitivity analyses where
we limited follow-up time to 5 and 10
years after baseline (when diabetes/
HbA1c category was defined) in order
to investigate the possible influence of
those with prediabetes and undiag-
nosed diabetes later being diagnosed
with diabetes on associations of base-
line diabetes/HbA1c category with
future hospitalization risk. We addition-
ally performed a sensitivity analysis to
assess the impact of diabetes duration.
In this analysis, a covariate was added to
our model split at diabetes duration of
3 years (,3 years [diagnosed with dia-
betes between ARIC visits 1 and 2] vs.
.3 years [diagnosed with diabetes prior
to ARIC visit 1]).
All reported P values were based on
two-sided tests, and P , 0.05 was con-
sidered statistically significant. Analyses
were performed using Stata, version 13
(StataCorp, College Station, TX).
RESULTS
Baseline characteristics (ARIC visit 2,
1990–1992) of the study population
are shown by HbA1c/diabetes category
in Table 1. Overall, mean age of partic-
ipants was 57 years, 56% were female,
24% were black, 17.8% had prediabe-
tes, 4.1% had undiagnosed diabetes,
and 9.3% had diagnosed diabetes.
Compared with those without a history
of diagnosed diabetes and HbA1c
,5.7%, those with prediabetes (HbA1c
5.7 to,6.5% and no diabetes diagnosis
history) were older (58 vs. 57 years, P,
0.001), more likely to be of black race
(40 vs. 16%, P, 0.001), and more likely
to have higher BMI (29 vs. 27 kg/m2,
P , 0.001). Similarly, those with un-
diagnosed diabetes (HbA1c$6.5% and
no diabetes diagnosis history) were
older (58 vs. 57 years, P , 0.001),
more likely to be of black race (51 vs.
16%, P, 0.001), and less likely to have
health insurance (83 vs. 94%, P ,
0.001) compared with those without a
history of diagnosed diabetes and
HbA1c ,5.7%. Among persons with di-
agnosed diabetes, those with HbA1c
,7.0 vs. $7.0% were of similar age
(58 years, P = 0.732), but those with
diabetes and HbA1c ,7.0% were less
likely to be of black race (34 vs. 49%,
P , 0.001). Cumulative mortality by
the end of follow-up was higher with
increasing diabetes/HbA1c category
(Ptrend , 0.001).
Supplementary Fig. 1 shows the crude
number of all-cause hospitalizations by
diabetes/HbA1c category over a median
of 20 years of follow-up. As HbA1c cat-
egory increased, the number of hospi-
talizations per person was higher, with
only 3.7% of participants without a his-
tory of diagnosed diabetes and HbA1c
,5.7% having $10 hospitalizations,
compared with 13.5% of those with di-
agnosed diabetes and HbA1c ,7.0%
and 18.2% of those with diagnosed di-
abetes and HbA1c $7.0%. The crude
rates per 1,000 person-years of all
cause-hospitalization by 10-year age-
group and by baseline diabetes/HbA1c
category are shown in Fig. 1. Rates of
all-cause hospitalization were higher at
older ages and were highest among
persons with higher HbA1c at baseline
(age ,60 years, no history of diag-
nosed diabetes, and HbA1c ,5.7%,
41.9 per 1,000 person-years, vs. diag-
nosed diabetes and HbA1c$7.0%, 93.2
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per 1,000person-years; age$80 years, no
history of diagnosed diabetes, and HbA1c
,5.7%, 372.3 per 1,000 person-years, vs.
diagnosed diabetes and HbA1c $7.0%,
673.8 per 1,000 person-years).
Table 2 shows the demographic ad-
justed rates per 1,000 person-years
(95% CI) of all-cause hospitalizations
by diabetes and HbA1c category from
negative binomial regression models.
Overall, the demographic adjusted
rates per 1,000 person-years of all-
cause hospitalizations were higher
with increasing diabetes/HbA1c cate-
gory (Ptrend , 0.001). Persons with di-
agnosed diabetes and HbA1c $7.0%
had the highest rates of hospitalization
(3.1 times higher than those without a
history of diagnosed diabetes and
HbA1c ,5.7%, P , 0.001). Among
those with diagnosed diabetes, those
with HbA1c $7.0% had significantly
higher demographic adjusted rate all-
cause hospitalization (504 per 1,000
person-years [95% CI 462–547]) com-
pared with those with HbA1c ,7.0%
(340 per 1,000 person-years [95% CI
297–384]) (P , 0.001). Among those
without a history of diagnosed diabe-
tes, persons with undiagnosed diabe-
tes (HbA1c $6.5%) had 1.6 times
higher rates of hospitalization and
those with prediabetes (HbA1c 5.7 to
,6.5%) had 1.3 times higher rates
of hospitalization than those with
HbA1c ,5.7% (P , 0.001 for both
comparisons). In tests of multiplicative
interaction, rates of all-cause hospital-
ization across diabetes/HbA1c cate-
gories differed by race and sex but
not by age. Rates of all-cause hospital-
ization by diabetes/HbA1c category
were higher for blacks compared with
whites for all diabetes/HbA1c cate-
gories except prediabetes (no history
of diagnosed diabetes and HbA1c 5.7
,6.5%) and undiagnosed diabetes
(no history of diagnosed diabetes and
HbA1c $6.5%) (P interaction = 0.011).
Rates of all-cause hospitalization by di-
abetes/HbA1c category were higher for
men compared with women in all
groups except for among those with
diagnosed diabetes and HbA1c $7.0%
Table 1—Participant characteristics by baseline diabetes and HbA1c category: the ARIC study, visit 2 (1990–1992)
No history of diagnosed diabetes
Diagnosed diabetes
HbA1c ,5.7%
HbA1c 5.7 to ,6.5%:
prediabetes
HbA1c $6.5%:
undiagnosed diabetes HbA1c ,7.0% HbA1c $7.0%
n 9,267 2,441 553 422 839
Age (years), mean (SD) 56.5 (5.7) 58.0 (5.7) 57.8 (5.7) 58.5 (5.7) 58.4 (5.7)
Female, % 56.1 52.5 58.2 53.6 57.7
Race, %
White 84.4 60.1 49.6 66.1 51.3
Black 15.6 39.9 50.5 33.9 48.8
Education, %
,High school 16.4 30.3 34.5 35.6 37.4
High school, GED, or vocational school 43.3 38.6 35.4 38.2 37.9
College, graduate, or professional school 40.3 31.1 30.0 27.3 24.7
Income ($), %
,35,000/year 44.9 60.8 65.6 66.8 70.0
$35,000/year 49.6 33.3 26.4 27.0 23.8
Not reported 5.5 6.0 8.0 6.2 6.2
Health insurance, % 93.7 88.5 82.5 88.2 85.3
Charlson Comorbidity Index $2, % 34.7 45.5 45.9 53.1 52.1
Smoking status, %
Never 40.7 34.3 38.9 38.9 45.7
Former 38.6 36.1 37.3 37.7 37.7
Current 20.7 29.6 23.9 23.5 16.7
Alcohol consumption, %
Never 20.4 24.4 30.0 26.5 33.3
Former 17.2 26.1 28.9 33.4 36.8
Current 62.5 49.5 41.1 40.1 29.9
BMI (kg/m2), mean (SD) 27.0 (4.8) 29.2 (5.8) 32.4 (6.1) 29.9 (5.9) 31.4 (6.0)
Hypertension, % 28.9 44.2 57.0 54.8 63.1
Systolic blood pressure (mmHg), mean (SD) 119.4 (18.1) 124.5 (19.1) 128.1 (17.7) 127.2 (20.7) 128.4 (20.3)
Diastolic blood pressure (mmHg), mean (SD) 71.8 (10.2) 73.3 (10.2) 74.2 (10.4) 71.2 (10.2) 71.0 (10.4)
Hypertension medication use, % 25.8 41.7 57.0 54.8 63.1
Coronary heart disease, % 4.5 7.1 6.5 10.7 14.9
Total cholesterol (mg/dL), mean (SD) 207.6 (38.0) 213.3 (39.9) 217.6 (42.1) 206.3 (40.0) 217.8 (49.4)
HDL cholesterol (mg/dL), mean (SD) 51.4 (17.2) 46.9 (14.9) 42.9 (13.8) 44.8 (14.6) 42.4 (14.4)
Cholesterol medication use, % 5.6 7.1 7.6 10.7 11.7
Estimated glomerular filtration rate
,60 mL/min/1.73 m2, % 1.4 2.4 2.9 6.9 6.8
Mortality by end of follow-up, % 23.7 38.8 42.7 48.6 63.4
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(Pinteraction = 0.020). Rates among those
who were older at baseline (.55 years)
were consistently higher than among
those who were younger at baseline
(#55 years) across all diabetes/HbA1c
categories (Pinteraction = 0.141). The higher
rates of all-cause hospitalization per
1,000 person-years across diabetes/
HbA1c categorieswere slightly attenuated
but remained significant with further ad-
justment for the Charlson Comorbidity In-
dex (Supplementary Table 1) and for
social/lifestyle and cardiovascular dis-
ease risk factors (Supplementary Table 2).
When an HbA1c cut point of 8.0% in-
stead of 7.0% was used to characterize
glycemic control among those with di-
agnosed diabetes, patterns of all-cause
hospitalization were similar but with
higher rates of all-cause hospitalization
in persons with HbA1c $8.0% compared
with HbA1c $7.0% (548 vs. 504 all-cause
hospitalizations per 1,000 person-years,
respectively) (Supplementary Table 3).
The pattern of higher rates of all-cause
hospitalization per 1,000 person-years
across diabetes/HbA1c categories re-
mained present when using zero-inflated
negative binomial regression models
(Supplementary Table 4). The pattern of
higher rates of all-cause hospitalization
per 1,000 person-years with increasing
glycemic category remained present
when participants were categorized
by diabetes/fasting glucose category
(Supplementary Table 5). In sensitivity
analyses limiting follow-up time to 5 and
10 years after baseline, associations of
diabetes/HbA1c category with hospital-
ization risk remained statistically sig-
nificant (P , 0.001 for prediabetes [no
history of diagnosed diabetes and
HbA1c 5.7 to ,6.5%], undiagnosed dia-
betes [no history of diagnosed diabetes
and HbA1c$6.5%], and diagnosed diabe-
tes with HbA1c ,7.0 and $7.0% com-
pared with no history of diagnosed
diabetes and HbA1c ,5.7% for follow-up
times of both 5 and 10 years). In sensitiv-
ity analyses looking at the impact of di-
abetes duration, diabetes duration was
moderately associated with risk of hospi-
talization, but this result was not signif-
icant at the P = 0.05 level (P = 0.102).
The primary causes for hospitalization
are shown according to history of diag-
nosed diabetes status in Fig. 2. Cardio-
vascular disease was the most common
primary cause for hospitalization among
those with and without a history of di-
agnosed diabetes in (crude rate 174.9
[95% CI 169.5–180.4] and 63.9 [95% CI
62.9–65.0] hospitalizations per 1,000
person-years, respectively, P , 0.001);
however, the most common specific
cardiovascular diagnosis was coronary
Figure 1—Crude rates of all-cause hospitalization per 1,000 person-years by 10-year age-group
and by baseline (1990–1992) diabetes and HbA1c category: the ARIC study, 1990–2011.
Table 2—Demographic adjusted* rates of all-cause hospitalization per 1,000 person-years (95% CI) by baseline (1990–1992)
diabetes and HbA1c category from negative binomial models: the ARIC study, 1990–2011
No history of diagnosed diabetes Diagnosed diabetes
Pinteraction§HbA1c ,5.7% HbA1c 5.7 to ,6.5% HbA1c $6.5% HbA1c ,7.0% HbA1c $7.0%
n 9,267 2,441 553 422 839
Total hospitalizations, n 24,972 8,668 2,221 2,113 5,098
Total person-years 169,983 41,641 9,190 6,779 11,848
Overall 163 (158–169) 217 (206–228)** 254 (226–281)** 340 (297–384)** 504 (462–547)**†
By race 0.011
White 161 (156–166) 223 (209–238)** 263 (225–302)** 297 (249–345)** 473 (423–524)**†
Black 170 (155–185) 209 (191–227)** 251 (211–291)** 433 (347–519)** 552 (481–622)**†
By sex 0.020
Men 186 (178–195) 248 (230–266)** 279 (231–327)** 397 (316–477)** 481 (424–537)**†
Women 146 (140–153) 195 (180–209)** 236 (203–269)** 301 (253–350)** 518 (459–578)**†
By baseline age 0.141
#55 years 118 (111–124) 163 (148–178)** 181 (145–217)** 280 (215–346)** 416 (356–477)**†
.55 years 209 (201–218) 270 (254–287)** 329 (287–372)** 405 (345–465)** 599 (539–658)**†
*Adjusted for age, sex, race/center, and insurance status. **P, 0.05, compared with HbA1c,5.7% (reference). †P, 0.05, HbA1c$7.0 vs.,7.0%
(reference). §Multiplicative interaction term.
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atherosclerosis for those without a his-
tory of diagnosed diabetes and con-
gestive heart failure for those with
diagnosed diabetes (Supplementary
Table 5). There were significant excess
rates of hospitalizations due to cardio-
vascular, endocrine, respiratory, gastro-
intestinal, iatrogenic/injury, neoplasm,
genitourinary, neurologic, and infection
causes among those with diagnosed di-
abetes compared with those without a
history of diagnosed diabetes (all P ,
0.05) (Fig. 2). In sensitivity analyses
using a more comprehensive infection
category definition, crude rates of hospi-
talizations with a primary cause of in-
fection were 12.6 (95% CI 12.1–13.1)
and 32.4 (95% CI 30.0–35.1) per 1,000
person-years among those without and
with a history of diagnosed diabetes,
respectively.
CONCLUSIONS
In this community-based population of
middle-aged white and black persons,
those with prediabetes, undiagnosed di-
abetes, and diagnosed diabetes had
significantly higher rates of all-cause
hospitalization over a median of 20
years of follow-up compared with those
without a history of diagnosed diabetes
and normal HbA1c (,5.7%), even after
adjustment for insurance status and
comorbidities. Further, among persons
with diagnosed diabetes, those with
poor glycemic control, as assessed by
HbA1c, had higher rates of all-cause hos-
pitalization compared with those with
lower HbA1c. Consistent with prior stud-
ies (19,20), hospitalization rates across
diabetes/HbA1c categories were higher
for older versus younger individuals.
Even after adjustment, hospitalization
rates were higher in blacks versus
whites among persons with diagnosed
diabetes, suggesting that blacks with
diabetes experience a higher burden
of morbidity from diabetes compared
with their white counterparts.Men had
higher rates of hospitalization versus
women (in all categories except for di-
agnosed diabetes with HbA1c $7.0%),
which contrasts with evidence from ep-
idemiologic studies showing no interac-
tion by sex in the association of HbA1c
with overall mortality (21,22). This ob-
served sex difference in hospitalization
rates suggests that while risk of mortal-
ity by HbA1c category may be similar by
sex, men without a diabetes diagnosis
or with well-controlled diabetes and
women with poorly controlled diabetes
are more likely to be hospitalized. We
identifiedmajor causes of hospitalizations
in persons with diabetes and showed
substantial risk of hospitalizations for
underlying endocrine causes (largely
diabetes-related), infection (including
pneumonia and urinary tract infec-
tions), and iatrogenic/injury causes (in-
cluding complications of device/implant/
graft, surgical complications, and frac-
tures), all of which may be preventable
with improved glycemic control.
Our study is consistent with previous
studies that showed high rates of hos-
pitalization among those with diabetes
compared with those without diabetes
(23–32) and studies of common causes
for hospitalization among those with
diabetes (23–25,33). However, in con-
trast to prior studies (23–25), we did
not identify infectious causes as one
of the most common causes of hospi-
talization (infection was ranked tenth).
This may be in part due to the ICD-9
code classification system that we
used in our primary analyses. While
the Clinical Classification Software de-
veloped by the Agency for Healthcare
Research and Quality (14) does have an
infection category, not all ICD-9 codes
that identify infection are classified in
that category (for example, pneumonia
is classified under the respiratory sys-
tem and not under the infection cate-
gory). Indeed, when we reclassified all
ICD-9 codes that related to infection,
we found that hospitalizations among
those with diagnosed diabetes due to
infectious causes occurred at a rate of
32 per 1,000 person-yearsdresults
that are more similar to prior studies
(23–25).
Prior studies of hospitalization rates
in persons with diabetes have been lim-
ited by cross-sectional designs (23,24),
short follow-up (,5 years) (25,27,30–32),
and/or by the use of ICD-9 codes to
define diabetes status (23,24,26,27).
Many prior studies also did not compare
hospitalization risk in persons with predi-
abetes or undiagnosed diabetes (23–32)
or evaluate potential differences by
age, sex, and race (23–27,30,31). Our
study had a median follow-up period
of 20 years in a community-based pop-
ulation, and we were able to rigorously
characterize and compare hospitaliza-
tion risk among those with diagnosed
diabetes by levels of HbA1c and in those
at high risk prior to a formal diagnosis of
diabetes (prediabetes and undiagnosed
diabetes). Our results extend the litera-
ture by showing not only that diagnosed
diabetes is associated with a higher risk
of hospitalization but also that predia-
betes and undiagnosed diabetes were
Figure 2—Crude rates of cause-specific hospitalization per 1,000 person-years by baseline
(1990–1992) diabetes status: the ARIC study, 1990–2011. *P , 0.05 comparing diabetes vs.
no diabetes.
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associated with a significant excess
rates of hospitalization later in life.
Consistent with prior studies establish-
ing that poorer glycemic control in mid-
life is associated with an increased risk
of complications andmortality (21,34–36),
we found that higher HbA1c values
in persons with diagnosed diabetes
were an important indicator of future
hospitalization risk later life. Our results
suggest that prevention of diabetes and
improved management of diabetes
could impact later-life hospitalization
risk.
Certain limitations should be taken
into consideration in the interpretation
of this study. First, although we ascer-
tained hospitalization data via both an-
nual telephone contact with study
participants and active surveillance of
hospitalizations occurring in all study
communities, some hospitalizations oc-
curring among ARIC participants (e.g.,
hospitalizations outside of the surveil-
lance areas that are not reported during
follow-up telephone calls) are likely not
captured in our data. Therefore, our re-
sults likely underestimate the true rates
of hospitalization in our population. Sec-
ond, we only had one measure of HbA1c,
and we were thus unable to apply time-
varying diabetes/HbA1c categories over
follow-up. However, in sensitivity ana-
lyses where follow-up time was limited
to 5 and 10 years after baseline, rates
of all-cause hospitalization remained
significantly higher for those with pre-
diabetes and undiagnosed diabetes
compared with those with normogly-
cemia, suggesting that prediabetes
and undiagnosed diabetes represent
groups at high risk that is not fully ex-
plained by a later diagnosis of diabetes.
We also did not have detailed data on
diabetes duration. However, we were
able to look at diabetes duration split
at 3 years (,3 years [diagnosed with
diabetes between ARIC visits 1 and 2]
vs. .3 years [diagnosed with diabetes
prior to ARIC visit 1]), which was not
significantly associated with hospitali-
zation. Additionally, we observed differ-
ential mortality by diabetes/HbA1c
category. Therefore, our relative hospi-
talization rates are likely an underesti-
mation due to competing mortality risk,
but we did include follow-up time as an
offset variable in our regressionmodels,
which served as a means to account for
this competing risk of death. The ARIC
study was recruited from four U.S. com-
munities and therefore may not be rep-
resentative of the entire U.S. population.
Further, all participants in the ARIC
study were given the option to have
their primary care doctor notified if
lab results were abnormal; therefore,
ARIC participants may receive a diagno-
sis of diabetes at an earlier point than
persons in the general community as a
result of being in the study. However, an
analysis in ARIC study participants
showed that diagnosis of diabetes was
still delayed on average by 2–7 years
after the study visit at which the glucose
was elevated (37).
In conclusion, in this community-
based longitudinal study, we found
that middle-aged persons with predia-
betes or diabetes had significantly ex-
cess rates of hospitalization during
two decades of follow-up. Randomized
clinical trials of glucose control have
typically enrolled high-risk patients,
have had limited follow-up, and have
focused on narrowly defined microvas-
cular and/or macrovascular outcomes.
Observational cohort studies, such as
ours, can provide comprehensive evi-
dence of the long-term risks of hyper-
glycemia. We found an excess risk of
total hospitalizations, and cardiovascu-
lar hospitalization in particular, not only
among persons with diagnosed diabe-
tes and poorly controlled diabetes but
also among those with undiagnosed di-
abetes and prediabetes. Our results
suggest that prevention of prediabetes
from progression to overt diabetes and
improved glycemic control among
those with diagnosed diabetes may re-
duce the burden of hospitalizations
over the life span. The high rate of hos-
pitalization due to endocrine, infection,
and iatrogenic/injury causes among
those with diagnosed diabetes is con-
cerning and suggests that increased ef-
forts are needed to reduce the burden
of preventable hospitalization among
persons with diabetes.
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